Clinical and Toxicological Analysis Department - Faculty of Pharmacy, Federal University of Minas Gerais, Brazil.
Clin Chim Acta. 2010 Feb;411(3-4):135-9. doi: 10.1016/j.cca.2009.11.022. Epub 2009 Nov 27.
Patients undergoing hemodialysis may show both thrombotic complications and bleeding abnormalities. Hemostatic changes in patients on hemodialysis may result from alterations in vessel wall integrity and platelet function, and reduced blood flow in the native arteriovenous fistula. Vascular complications represent 20-25% of all hospitalizations of patients on hemodialysis. Literature survey revealed that changes in the hemostatic system may play a major role in vascular complications observed in these patients. Thus, it is essential to investigate hemostatic alterations in patients on hemodialysis so that adequate regimes for anticoagulant therapy could be implemented. In this review we discuss hemostatic abnormalities in end stage renal disease patients undergoing hemodialysis.
接受血液透析的患者可能会出现血栓并发症和出血异常。血液透析患者的止血变化可能是由于血管壁完整性和血小板功能改变以及天然动静脉瘘中的血流减少所致。血管并发症占血液透析患者所有住院治疗的 20-25%。文献调查显示,止血系统的变化可能在这些患者观察到的血管并发症中起主要作用。因此,有必要研究血液透析患者的止血变化,以便能够实施足够的抗凝治疗方案。在这篇综述中,我们讨论了接受血液透析的终末期肾病患者的止血异常。